telehealth doctors prescribe glp-1 weight loss medications TrimRX Remote Weight Loss Telehealth |

For many patients, hunger returns, sometimes intensely, and without the drugs support, maintaining the same caloric intake becomes significantly harder

The Clinical Data: Everything Published So Far Phase 1 First-in-Human (Oral Formulation) Published: The Lancet, June 2025 Participants: 144 adults with overweight or obesity (BMI 25.039.9), no diabetes Duration: Up to 12 weeks Dosing: Once-daily oral amycretin, up to 2 50 mg Results: - 50 mg dose: 10.4% mean body weight change - 2 50 mg dose: 13.1% mean body weight change - Placebo: 1.2% 13% weight loss in 12 weeks

GLP-1 users were also less risky than in the prior year, while non-GLP-1 users became riskier

Excess weight can increase pressure on your upper airways and this can stop you from breathing for short periods of time during sleep

Typically, the treatment involves weekly injections that gradually increase in dosage to minimize side effects

However, we found selective expression of the receptor for Glp-1 (Glp1r) in a subset of myenteric neurons (Fig